CRP and melanoma: To elaborate especially the immunomodulatory impact of PEVs on melanoma, we performed another RNA-seq with the CRP and FFV PEV-treated A2058 spheroids at 6 h and 24 h (Fig. 5A) and compared the results with untreated spheroids.